Literature DB >> 24271498

WITHDRAWN: Radiotherapy for the palliation of painful bone metastases.

Henry J McQuay1, Sally L Collins, Dawn Carroll, R Andrew Moore, Sheena Derry.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24271498      PMCID： PMC6564087          DOI： 10.1002/14651858.CD001793.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN： 1361-6137


× No keyword cloud information.
  40 in total

1.  [A randomized trial of single and multifraction radiation therapy for bone metastasis: a preliminary report].

Authors:  K Kagei; K Suzuki; H Shirato; T Nambu; H Yoshikawa; G Irie
Journal:  Gan No Rinsho       Date:  1990-12

2.  Randomized prospective clinical study of small, large and twice-a-day fraction radiotherapy for painful bone metastases.

Authors:  T Okawa; M Kita; M Goto; H Nishijima; N Miyaji
Journal:  Radiother Oncol       Date:  1988-10       Impact factor: 6.280

3.  Results of a double blind study of 89-strontium therapy of skeletal metastases of prostatic carcinoma.

Authors:  K Buchali; H J Correns; M Schuerer; D Schnorr; H Lips; K Sydow
Journal:  Eur J Nucl Med       Date:  1988

4.  Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placebo.

Authors:  H R Maxon; L E Schroder; V S Hertzberg; S R Thomas; E E Englaro; R Samaratunga; H Smith; J S Moulton; C C Williams; G J Ehrhardt
Journal:  J Nucl Med       Date:  1991-10       Impact factor: 10.057

5.  A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone.

Authors:  V J Lewington; A J McEwan; D M Ackery; R J Bayly; D H Keeling; P M Macleod; A T Porter; M A Zivanovic
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

6.  [Drug therapy with disodium clodronate combined with radiotherapy of bone metastasis of solid tumors].

Authors:  M Botturi; D Zanni; G Tosi
Journal:  Radiol Med       Date:  1990-11       Impact factor: 3.469

7.  A report of RTOG 8206: a phase III study of whether the addition of single dose hemibody irradiation to standard fractionated local field irradiation is more effective than local field irradiation alone in the treatment of symptomatic osseous metastases.

Authors:  C A Poulter; D Cosmatos; P Rubin; R Urtasun; J S Cooper; R R Kuske; N Hornback; C Coughlin; I Weigensberg; M Rotman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

8.  A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain.

Authors:  P J Hoskin; P Price; D Easton; J Regan; D Austin; S Palmer; J R Yarnold
Journal:  Radiother Oncol       Date:  1992-02       Impact factor: 6.280

9.  Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions. Report to the Medical Research Council by its Lung Cancer Working Party.

Authors: 
Journal:  Br J Cancer       Date:  1991-02       Impact factor: 7.640

10.  A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Medical Research Council Lung Cancer Working Party.

Authors: 
Journal:  Br J Cancer       Date:  1992-06       Impact factor: 7.640
View more
  2 in total

Review 1.  Metastatic disease in head & neck oncology.

Authors:  Paolo Pisani; Mario Airoldi; Anastasia Allais; Paolo Aluffi Valletti; Mariapina Battista; Marco Benazzo; Roberto Briatore; Salvatore Cacciola; Salvatore Cocuzza; Andrea Colombo; Bice Conti; Alberto Costanzo; Laura Della Vecchia; Nerina Denaro; Cesare Fantozzi; Danilo Galizia; Massimiliano Garzaro; Ida Genta; Gabriela Alejandra Iasi; Marco Krengli; Vincenzo Landolfo; Giovanni Vittorio Lanza; Mauro Magnano; Maurizio Mancuso; Roberto Maroldi; Laura Masini; Marco Carlo Merlano; Marco Piemonte; Silvia Pisani; Adriele Prina-Mello; Luca Prioglio; Maria Gabriella Rugiu; Felice Scasso; Agostino Serra; Guido Valente; Micol Zannetti; Angelo Zigliani
Journal:  Acta Otorhinolaryngol Ital       Date:  2020-04       Impact factor: 2.124

2.  How should we describe the benefits of palliative radiotherapy?

Authors:  R Samant; T Tucker
Journal:  Curr Oncol       Date:  2006-12       Impact factor: 3.677
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.